These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 3771814)

  • 81. Bromazepam, another high-potency benzodiazepine, for panic attacks.
    Beaudry P; Fontaine R; Chouinard G
    Am J Psychiatry; 1984 Mar; 141(3):464-5. PubMed ID: 6142658
    [No Abstract]   [Full Text] [Related]  

  • 82. Gepirone and the treatment of panic disorder: an open study.
    Pecknold JC; Luthe L; Scott-Fleury MH; Jenkins S
    J Clin Psychopharmacol; 1993 Apr; 13(2):145-9. PubMed ID: 8096526
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Secondary depression in panic disorder and agoraphobia. II. Dimensions of depressive symptomatology and their response to treatment.
    Lesser IM; Rubin RT; Rifkin A; Swinson RP; Ballenger JC; Burrows GD; Dupont RL; Noyes R; Pecknold JC
    J Affect Disord; 1989; 16(1):49-58. PubMed ID: 2521651
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Prescribing patterns in agoraphobia with panic attacks.
    Evans LE; Oei TP; Hoey H
    Med J Aust; 1988 Jan; 148(2):74-7. PubMed ID: 3336339
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Alprazolam levels and response in panic disorder: preliminary results.
    Wincor MZ; Munjack DJ; Palmer R
    J Clin Psychopharmacol; 1991 Feb; 11(1):48-51. PubMed ID: 2040715
    [TBL] [Abstract][Full Text] [Related]  

  • 86. HPA axis disturbance and treatment outcome in panic disorder.
    Coryell W; Noyes R
    Biol Psychiatry; 1988 Nov; 24(7):762-6. PubMed ID: 3067754
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Fluoxetine in panic disorder patients with imipramine-associated weight gain.
    Brady K; Zarzar M; Lydiard RB
    J Clin Psychopharmacol; 1989 Feb; 9(1):66-7. PubMed ID: 2785123
    [No Abstract]   [Full Text] [Related]  

  • 88. Antidepressants in panic disorder and agoraphobia.
    Lydiard RB; Ballenger JC
    J Affect Disord; 1987; 13(2):153-68. PubMed ID: 2960710
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Adinazolam-SR in panic disorder with agoraphobia: relationship of daily dose to efficacy.
    Carter CS; Fawcett J; Hertzman M; Papp LA; Jones W; Patterson WM; Swinson RP; Weise CC; Maddock RJ; Denahan AQ
    J Clin Psychiatry; 1995 May; 56(5):202-10. PubMed ID: 7737960
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Reduction in hypochondriasis with treatment of panic disorder.
    Noyes R; Reich J; Clancy J; O'Gorman TW
    Br J Psychiatry; 1986 Nov; 149():631-5. PubMed ID: 3814956
    [TBL] [Abstract][Full Text] [Related]  

  • 91. The genetics of panic disorder and agoraphobia.
    Crowe RR
    Psychiatr Dev; 1985; 3(2):171-85. PubMed ID: 2864687
    [TBL] [Abstract][Full Text] [Related]  

  • 92. [What is the result of an inpatient treatment program with client-centered psychotherapy emphasis in patients with agoraphobia and/or panic? Results of a 1-year follow-up].
    Teusch L; Böhme H
    Psychother Psychosom Med Psychol; 1991 Feb; 41(2):68-76. PubMed ID: 2027930
    [TBL] [Abstract][Full Text] [Related]  

  • 93. [Panic attacks and anxiety depression. Clinical, biological and therapeutic update].
    Martinot JL; Raffaitin F; Olié JP
    Encephale; 1986; 12(6):321-6. PubMed ID: 3816679
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Alpidem in the treatment of panic disorder.
    Schneier FR; Carrasco JL; Hollander E; Campeas R; Fallon B; Saoud JB; Feerick J; Liebowitz MR
    J Clin Psychopharmacol; 1993 Apr; 13(2):150-3. PubMed ID: 8096527
    [TBL] [Abstract][Full Text] [Related]  

  • 95. A double-blind study of the efficacy of venlafaxine extended-release, paroxetine, and placebo in the treatment of panic disorder.
    Pollack MH; Lepola U; Koponen H; Simon NM; Worthington JJ; Emilien G; Tzanis E; Salinas E; Whitaker T; Gao B
    Depress Anxiety; 2007; 24(1):1-14. PubMed ID: 16894619
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Psychopharmacological investigation of panic disorder by means of lactate infusion.
    Murray JB
    J Gen Psychol; 1987 Jul; 114(3):297-311. PubMed ID: 3612109
    [TBL] [Abstract][Full Text] [Related]  

  • 97. [Panic attacks and panic syndrome--diagnosis and therapy].
    Katschnig H; Nutzinger DO
    Psychiatr Prax; 1990 Jan; 17(1):2-12. PubMed ID: 2179978
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Sodium valproate and clonazepam for treatment-resistant panic disorder.
    Ontiveros A; Fontaine R
    J Psychiatry Neurosci; 1992 Jun; 17(2):78-80. PubMed ID: 1637803
    [TBL] [Abstract][Full Text] [Related]  

  • 99. [The dexamethasone suppression test in agoraphobia with panic attacks. 30 cases].
    Cottraux J; Claustrat B
    Encephale; 1984; 10(6):267-72. PubMed ID: 6529933
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Some biochemical correlates of panic attacks with agoraphobia and their response to a new treatment.
    Sheehan DV; Coleman JH; Greenblatt DJ; Jones KJ; Levine PH; Orsulak PJ; Peterson M; Schildkraut JJ; Uzogara E; Watkins D
    J Clin Psychopharmacol; 1984 Apr; 4(2):66-75. PubMed ID: 6142907
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.